Tarsus Pharmaceuticals, Inc. Annual Interest Expense in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Tarsus Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2021 to 2023.
  • Tarsus Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $983K, a 43.7% increase year-over-year.
  • Tarsus Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $3.65M, a 42% increase year-over-year.
  • Tarsus Pharmaceuticals, Inc. annual Interest Expense for 2023 was $3.35M, a 52.2% increase from 2022.
  • Tarsus Pharmaceuticals, Inc. annual Interest Expense for 2022 was $2.2M.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.35M +$1.15M +52.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $2.2M +$2.2M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.